StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) bonds

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.19−0.01 (-5.56%)

Close on Nov 17, 2026Market cap $2.58MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$7.05M
$1.07M due within a year
Net debt
$4.25M
After $2.80M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in VolitionRx's 10-Q for the period ended Jun 30, 2026

IssueAmount issuedCarrying value
Convertible Notes Payable
Convertible
$7.50M–
Convertible Notes Payable Two Thousand Twenty Five
Convertible
–$3.38M
Convertible Notes Payable Two Thousand Twenty Five And Two Thousand Twenty Six Lind Note
Convertible
–$5.77M
Convertible Notes Payable Two Thousand Twenty Six
Convertible
–$2.39M
Notes Payable$2.40M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?